Lunit and microsoft collaborate to advance ai-driven cancer diagnosis

Seoul, south korea , july 2, 2025 /prnewswire/ -- lunit (krx:328130.kq), a leading provider of ai for cancer diagnostics and therapeutics, today announced a collaboration with microsoft to accelerate the delivery of ai-powered healthcare solutions. in conjunction with their recent acquisition of volpara, a microsoft industry health certified partner, this collaboration will give health professionals globally access to tools that will assist in the detection of cancer.
MSFT Ratings Summary
MSFT Quant Ranking